Beh çet syndrome: effects of Pycnogenol® supplementation during regression phases.
CONCLUSIONS: Pycnogenol® may be a useful supplementation for the management of BS.
PMID: 29975020 [PubMed - in process] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - July 7, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
An overview on STEMI.
Authors: Menozzi A
PMID: 29975021 [PubMed - in process] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - July 7, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Percutaneous tricuspid annuloplasty.
Authors: Donatelle M, Lim DS
Abstract
Severe tricuspid regurgitation (TR) is a common problem, affecting approximately 1.6 million Americans, with the majority (85%) of TR being functional in nature. When left untreated, TR is associated with progressive right-sided heart failure, with a poor prognosis entailing high morbidity and mortality. Surgical repair is still the gold standard for TR, but only a small proportion of patients undergo surgical repair leaving a high clinical demand for alternatives to conventional surgery. Percutaneous repair and replacement of cardiac valves have exponentially advanced...
Source: Minerva Cardioangiologica - July 4, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
The future of percutaneous tricuspid valve interventions.
Authors: Regazzoli D, Mangieri A, Demir O, Ancona MB, Lanzillo G, Giannini F, Leone PP, Colombo A, Latib A
Abstract
Tricuspid valve regurgitation has a high prevalence and, when severe, is associated with poor outcomes. Nevertheless, surgical repair or replacement (isolated or as a part of a combined procedure) is rarely performed due to high surgical risk. Therefore, there is a significant unmet clinical need for percutaneous transcatheter-based treatments. Significant development in percutaneous therapies for both aortic and mitral valve disease has been accomplished over the last two decades, while tran...
Source: Minerva Cardioangiologica - July 4, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Prevention of recurrent venous thrombosis and post-thrombotic syndrome.
CONCLUSIONS: Interaction between PTS and R-DVT are complex; recurrences cause more PTSs, and a post-thrombotic limb is prone to R-DVT. Aspirin, for patients that can tolerate it, reduces the occurrence of PTS and R-DVT. In addition, ticlopidine and sulodexide are effective. Pycnogenol® is the most effective and safe for R-DVT and particularly PTS. Its full range of anti-thrombotic activity is now under evaluation.
PMID: 29795059 [PubMed - in process] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - May 31, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
A simple prognostic index in acute heart failure.
CONCLUSIONS: A simple prognostic index based on variables easily assessed can be useful to predict mortality in acute heart failure at the first arrival in hospital.
PMID: 29808977 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - May 31, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Alcohol use disorders, cardiomyopathy and heart transplantation: a new management.
Authors: Testino G, Bottaro LC, Balbinot P, Leone S, Pellicano R
PMID: 29792019 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - May 27, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Revascularization of serious atherosclerotic systemic artery stenosis caused by long-term primary hypertension in a 30-year-old male.
Authors: Ma G, Fang J, Zhang Z, Zhou L, Gao X, Zhao H, Shen A, Chen H, Li H
PMID: 29745628 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - May 11, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Long-term prognostic impact of non-invasive follow-up with computed tomography angiography in patients with left main coronary artery stenting.
CONCLUSIONS: Elective 6-month CTA after LMCA stenting is associated with better outcomes compared to conventional clinical follow-up.
PMID: 29687696 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - April 25, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
The association of the S447X mutation in LPL with coronary artery disease: a meta-analysis.
CONCLUSIONS: The results indicated G allelic could significantly decrease CAD and MI risk.
PMID: 29687697 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - April 25, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Microcirculatory dysfunction in the heart and the brain.
Authors: Mejía-Rentería H, Matias-Guiu JA, Lauri F, Yus M, Escaned J
Abstract
Coronary microcirculatory dysfunction is a major cause of myocardial ischemia that influences the outcomes of patients with coronary artery disease. The mechanisms of coronary microcirculatory dysfunction are heterogeneous and may result from a spectrum of biological and cardiovascular risk factors that may affect also the microcirculation of other vital organs. Microcirculatory dysfunction of the brain, known as cerebral small vessel disease, is increasingly being recognized as a cause of cognitive decline and neurodegenerativ...
Source: Minerva Cardioangiologica - April 25, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Merging the properties of a sirolimus coated balloon with those of a bioresorbable polymer sirolimus eluting stent to address the "diabetes issue". Results from the En-Abl multicenter registry.
CONCLUSIONS: The performance of the Abluminus DES+ is consistent among patients with or without diabetes, regardless the insulin dependency.
PMID: 29687699 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - April 25, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Impella: pumps overview and access site management.
Authors: Burzotta F, Russo G, Previ L, Bruno P, Aurigemma C, Trani C
Abstract
The Impella left ventricular support system consists of two main components: a family of different ventricular support catheters with a microaxial pump to be placed across the aortic valve and a single external controller (AIC) which is connected to activate and control the pump function. Four Impella left ventricular support catheters are available: Impella 2.5, Impella CP, Impella 5.0 and Impella LD. Impella 2.5 and Impella CP are designed for percutaneous peripheral insertion, have respectively a 12F and 14F maximal diameter a...
Source: Minerva Cardioangiologica - April 25, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
"Protected" PCI: time to act.
Authors: Burzotta F, Crea F
PMID: 29687701 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - April 25, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
New-generation devices for transcatheter aortic valve implantation.
Authors: Gatto L, Biondi-Zoccai G, Romagnoli E, Frati G, Prati F, Giordano A
Abstract
Transcatheter aortic valve implantation (TAVI) has overcome the pioneering phase and thanks to accrued clinical evidence has become a mainstay alternative to surgical aortic valve replacement (SAVR) in patients at high risk for post-operative complications. Despite these successes, TAVI remains a junior technology facing momentous developments in techniques and devices. Indeed, several new-generation devices for TAVI have become available in the last few years, including Acurate, Allegra, Evolut, Lotus, JenaValve, Portico...
Source: Minerva Cardioangiologica - April 25, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
